ATE73334T1 - Antioestrogenes arzneimittel zur perkutanen verabreichung. - Google Patents

Antioestrogenes arzneimittel zur perkutanen verabreichung.

Info

Publication number: ATE73334T1
Authority: AT; Austria
Prior art keywords: pct; drug; antioestrogenic; percutaneous administration; affections
Prior art date: 1984-01-20

Application number

AT85900469T

Other languages

English (en)

Inventor

Pierre Mauvais-Jarvis

Frederique Kuttenn

Original Assignee

Mauvais Jarvis Pierre

Frederique Kuttenn

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-01-20

Filing date

1984-12-21

Publication date

1992-03-15

1984-12-21 Application filed by Mauvais Jarvis Pierre, Frederique Kuttenn filed Critical Mauvais Jarvis Pierre

1992-03-15 Application granted granted Critical

1992-03-15 Publication of ATE73334T1 publication Critical patent/ATE73334T1/de

Links

230000001833 anti-estrogenic effect Effects 0.000 title abstract 2
229940079593 drug Drugs 0.000 title abstract 2
239000003814 drug Substances 0.000 title abstract 2
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 2
210000000481 breast Anatomy 0.000 abstract 2
229940046836 anti-estrogen Drugs 0.000 abstract 1
239000000328 estrogen antagonist Substances 0.000 abstract 1
-1 p-dimethylaminoethoxyphenyl Chemical group 0.000 abstract 1
229960003387 progesterone Drugs 0.000 abstract 1
239000000186 progesterone Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Steroid Compounds (AREA)

AT85900469T 1984-01-20 1984-12-21 Antioestrogenes arzneimittel zur perkutanen verabreichung. ATE73334T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR8400927A FR2558373B1 (fr)	1984-01-20	1984-01-20	Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
PCT/EP1984/000436 WO1985003228A1 (fr)	1984-01-20	1984-12-21	Medicament antioestrogene pour administration percutanee
EP85900469A EP0169214B1 (de)	1984-01-20	1984-12-21	Antiöstrogenes arzneimittel zur perkutanen verabreichung

Publications (1)

Publication Number	Publication Date
ATE73334T1 true ATE73334T1 (de)	1992-03-15

Family

ID=9300348

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT85900469T ATE73334T1 (de)	1984-01-20	1984-12-21	Antioestrogenes arzneimittel zur perkutanen verabreichung.

Country Status (8)

Country	Link
US (1)	US4919937A (de)
EP (2)	EP0151326B1 (de)
JP (1)	JPH0667826B2 (de)
AT (1)	ATE73334T1 (de)
DE (1)	DE3485581D1 (de)
DK (1)	DK155143C (de)
FR (1)	FR2558373B1 (de)
WO (1)	WO1985003228A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8604528D0 (en) *	1986-02-24	1986-04-03	Ici Plc	Therapeutic agents
IL93693A (en) *	1989-03-10	2000-01-31	Endorech Inc	Pharmaceutical compositions for the treatment of estrogen sensitive diseases
US5119827A (en) *	1990-09-05	1992-06-09	Board Of Regents, The University Of Texas System	Mechanisms of antiestrogen resistance in breast cancer
US5705185A (en) *	1991-09-25	1998-01-06	Beta Pharmaceuticals Co.	Transdermal delivery of estradiol and process for manufacturing said device
US5518734A (en) *	1991-09-25	1996-05-21	Beta Pharmaceuticals Co.	Transdermal delivery system for estradiol and process for manufacturing said device
GB9207437D0 (en) *	1992-04-03	1992-05-20	Orion Yhtymae Oy	Topical administration of toremifene and its metabolites
US5543150A (en) *	1993-09-15	1996-08-06	Columbia Laboratories, Inc.	Method of progesterone delivery and affect thereof
DE4407742C1 (de) *	1994-03-08	1995-06-22	Hexal Pharma Gmbh	Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat
JP2001500841A (ja) *	1996-03-29	2001-01-23	エスヴェーパテントフェアヴェアツングスゲゼルシャフトミットベシュレンクテルハフツンク	障害された皮下結合脂肪組織、とりわけ脂肪性浮腫の場合における皮膚を引きしめ滑らかにするための化粧品および化粧用組成物
RU2123838C1 (ru) *	1996-07-31	1998-12-27	Акционерное общество открытого типа "Нижфарм"	Состав для лечения гирсутизма
US20020086856A1 (en)	1998-03-18	2002-07-04	Alfred Schmidt	Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor
EP0943333A1 (de) *	1998-03-18	1999-09-22	S.W. Patentverwertungs GmbH	Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen
FI982733L (fi) *	1998-12-17	2000-06-18	Orion Yhtymae Oyj	Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
US7947275B2 (en)	2000-05-10	2011-05-24	Signe Biopharma, Inc.	Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
US8119138B2 (en) *	2000-05-10	2012-02-21	Signe Biopharma Inc.	Anti-estrogen and immune modulator combinations for treating breast cancer
US7863011B2 (en) *	2000-05-10	2011-01-04	Signe Biopharma, Inc.	Screening method for predicting susceptibility to breast cancer
US6503894B1 (en)	2000-08-30	2003-01-07	Unimed Pharmaceuticals, Inc.	Pharmaceutical composition and method for treating hypogonadism
US20040092494A9 (en) *	2000-08-30	2004-05-13	Dudley Robert E.	Method of increasing testosterone and related steroid concentrations in women
DE10054294A1 (de) *	2000-11-02	2002-05-16	Heinrich Wieland	Topische Behandlung bei der Mastalgie
WO2003041654A2 (en) *	2001-11-14	2003-05-22	Sirbasku David A	Anti-estrogen and immune modulator combinations for treating breast cancer
PL370889A1 (en) *	2001-12-20	2005-05-30	Femmepharma, Inc.	Vaginal delivery of drugs
EP1572171B1 (de) *	2002-12-18	2009-04-22	Laboratoires Besins International	Verringerung der dichte des brustgewebes durch 4-hydroxy tamoxifen
EP1572178B1 (de) *	2002-12-18	2006-05-03	Laboratoires Besins International	Behandlung von mastalgie mit4-hydroxy-tamoxifen
US9173836B2 (en)	2003-01-02	2015-11-03	FemmeParma Holding Company, Inc.	Pharmaceutical preparations for treatments of diseases and disorders of the breast
EP1578421A4 (de) *	2003-01-02	2009-04-22	Femmepharma Holding Co Inc	Pharmazeutische präparate für diebehandlung von erkrankungen und pathologischen zuständen der brust
NZ542499A (en) *	2003-04-01	2008-10-31	Besins Int Lab	Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
JP4682129B2 (ja) *	2003-06-09	2011-05-11	アセンドセラピュティクスインコーポレイテッド	４−ヒドロキシタモキシフェンによる過剰瘢痕化の治療及び予防
US7968532B2 (en) *	2003-12-15	2011-06-28	Besins Healthcare Luxembourg	Treatment of gynecomastia with 4-hydroxy tamoxifen
CA2549824C (en) *	2003-12-15	2012-03-13	Laboratoires Besins International	Use of 4-hydroxytamoxifen for the preparation of a medicament for the treatment of gynecomastia
EP1550440A1 (de) *	2003-12-15	2005-07-06	Laboratoires Besins International	Verwendung von 4-hydroxytamoxifen zur Herstellung eines Arzneimittels zur Behandlung von Gynäkomastie
US7507769B2 (en) *	2004-03-22	2009-03-24	Laboratoires Besins International	Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
US20050208139A1 (en) *	2004-03-22	2005-09-22	Ascend Therapeutics, Inc.	Chemically stable compositions of 4-hydroxy tamoxifen
NZ549817A (en) *	2004-03-22	2010-06-25	Besins Int Lab	Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
EP1579856A1 (de) *	2004-03-22	2005-09-28	Laboratoires Besins International	4-Hydroxytamoxifen zur Behandlung von benignen Brusterkrankungen
EP1647271A1 (de) *	2004-10-14	2006-04-19	Laboratoires Besins International	Gelzubereitung enthaltend 4-Hydroxy tamoxifen.
MX2007004371A (es) *	2004-10-14	2007-06-07	Besins Int Lab	Formulaciones de 4-hidroxitamoxifen en gel.
US20070088012A1 (en) *	2005-04-08	2007-04-19	Woun Seo	Method of treating or preventing type-2 diabetes
DK2450041T3 (en)	2005-10-12	2018-11-19	Unimed Pharmaceuticals Llc	Enhanced testosterone gel for use in the treatment of hypogonadism
KR100850910B1 (ko) *	2006-12-22	2008-08-07	삼성전자주식회사	블루투스 디바이스를 연결하기 위한 장치 및 방법
US20080153789A1 (en) *	2006-12-26	2008-06-26	Femmepharma Holding Company, Inc.	Topical administration of danazol
US20110003000A1 (en) *	2009-07-06	2011-01-06	Femmepharma Holding Company, Inc.	Transvaginal Delivery of Drugs
AU2017312499B2 (en)	2016-08-19	2023-02-02	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0002097B1 (de) *	1977-08-22	1981-08-05	Imperial Chemical Industries Plc	Triphenylalken-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
DE3046719C2 (de) *	1980-12-11	1983-02-17	Klinge Pharma GmbH, 8000 München	1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel
FR2515041A1 (fr)	1981-10-26	1983-04-29	Besins Jean	Medicament a base de progesterone pour le traitement des affections mammaires

1984
- 1984-01-20 FR FR8400927A patent/FR2558373B1/fr not_active Expired
- 1984-12-19 EP EP84201920A patent/EP0151326B1/de not_active Expired
- 1984-12-21 WO PCT/EP1984/000436 patent/WO1985003228A1/fr not_active Ceased
- 1984-12-21 JP JP60500495A patent/JPH0667826B2/ja not_active Expired - Fee Related
- 1984-12-21 US US06/777,786 patent/US4919937A/en not_active Expired - Lifetime
- 1984-12-21 EP EP85900469A patent/EP0169214B1/de not_active Expired - Lifetime
- 1984-12-21 DE DE8585900469T patent/DE3485581D1/de not_active Expired - Lifetime
- 1984-12-21 AT AT85900469T patent/ATE73334T1/de not_active IP Right Cessation
1985
- 1985-09-17 DK DK420385A patent/DK155143C/da active

Also Published As

Publication number	Publication date
DK155143B (da)	1989-02-20
WO1985003228A1 (fr)	1985-08-01
DK420385A (da)	1985-09-17
JPH0667826B2 (ja)	1994-08-31
JPS61500914A (ja)	1986-05-08
EP0169214A1 (de)	1986-01-29
EP0151326A1 (de)	1985-08-14
FR2558373B1 (fr)	1987-07-03
FR2558373A1 (fr)	1985-07-26
EP0169214B1 (de)	1992-03-11
DK155143C (da)	1989-07-03
DK420385D0 (da)	1985-09-17
US4919937A (en)	1990-04-24
DE3485581D1 (de)	1992-04-16
EP0151326B1 (de)	1989-07-12

Legal Events

Date	Code	Title	Description
1992-10-15	UEP	Publication of translation of european patent specification
2005-03-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
ATE73334T1 (de)	1992-03-15	Antioestrogenes arzneimittel zur perkutanen verabreichung.
ATE73331T1 (de)	1992-03-15	Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE3860043D1 (de)	1990-04-05	Verwendung von biertreberextrakt zur herstellung von medizinischen und kosmetischen zubereitungen.
BRPI0411255A (pt)	2006-08-01	composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto
ATE17079T1 (de)	1986-01-15	Praeparat zur behandlung von wunden der hautoberflaeche und verfahren zur herstellung des praeparats.
EG20001A (en)	1997-03-27	Process for preparing of novel hydrox-amic acid and N-hydroxyurea derivatives and their use
HUP9801234A2 (hu)	1999-01-28	Nitroglicerint tartalmazó, vizes alapú, helyileg alkalmazható krém, eljárás előállítására és alkalmazása
IS1565B (is)	1994-12-13	Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
EP0009688A3 (en)	1980-08-06	Medicated animal food based on liver powder, process for its preparation and its use in combating animal diseases
ATE55695T1 (de)	1990-09-15	Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
NO166939C (no)	1991-09-18	Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
ES478967A1 (es)	1980-08-16	Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
ATE302594T1 (de)	2005-09-15	Zubereitungen zur aknebehandlung
US2666013A (en)	1954-01-12	Pruritus therapy
EP0754456A3 (de)	2000-02-02	Topische Verwendung von ST1435 zur Empfängnisverhütung
ATE223721T1 (de)	2002-09-15	Edelfosin zur behandlung von hirntumoren
FR2439194A1 (fr)	1980-05-16	Derives de la dibenzothiepine, leur procede de preparation et leur application therapeutique
BR8008818A (pt)	1981-06-23	Peptidos farmacologicamente ativos e medicamentos contendo os mesmos
IE45054L (en)	1977-11-08	Veterinary composition
US2937974A (en)	1960-05-24	Process for preparing a modified lactalbumin hydrolysate
ES2006121A6 (es)	1989-04-01	Procedimiento para la preparacion de una composicion farmaceutica destinada al tratamiento de enfermedades cutaneas.
ATE143946T1 (de)	1996-10-15	N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
KR880002535A (ko)	1988-05-09	약제로서의 15-데옥시스퍼구알린의 용도
Hare et al.	1956	Acrodermatitis enteropathica
ATE207353T1 (de)	2001-11-15	Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden